Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...

Survey results show that clinicians largely disagree about choices for severe asthma treatment, due primarily to a lack of ...

Industry insiders are pushing to fix the small molecule ‘penalty’ by setting their hopes on a Republican majority.

Spring allergy season is expected to worsen in 2025. Longer growing seasons due to climate change have caused seasonal ...

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...

Immunology is one of the most profitable disease areas for pharma, with several of the world’s best-selling drugs falling under its umbrella. But it is also facing more disruption than most ...

With approximately one third of all current FDA-approved drugs targeting GPCRs, Verily/Sosei Heptares are looking to expedite GPCR research within not only immunology, but also gastroenterology ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

A UK biotech start-up with a 3D human lung model that provides an alternative to animal testing has raised a further £600,000 from the Midlands Engine Investment Fund, Mercia Ventures and Pioneer ...

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

Care that seeks to prevent disease, promote health, and prolong and enhance the quality of life, is not considered necessary, ...